All In MedTech

FDA Clearance Tracker · P990071-S009

THERMOCOOL SF NAV BI-DIRECTIONAL CATHETER (D1313-XX-S, D-1317-XX-S) AND THERMOCOOL SF BI-DIRECTIONAL CATHETER

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 21, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 21, 2011

Approved

Time to decision

705 days

Received Jan 15, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P990071-S009
Device name
THERMOCOOL SF NAV BI-DIRECTIONAL CATHETER (D1313-XX-S, D-1317-XX-S) AND THERMOCOOL SF BI-DIRECTIONAL CATHETER
Applicant location
Irvine, CA
Received
Jan 15, 2010
Decided
Dec 21, 2011
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P990071

Device type

Device class
Class III

Every decision under product code OAE

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE FOLLOWING DEVICE MODIFICATIONS:1) REDUCED RECOMMENDED SALINE FLOW RATE (REDUCE BY ~50%); 2) INCREASE IN NUMBER OF IRRIGATION HOLES (FROM 6 TO 56); 3) DECREASE IN SIZE OF IRRIGATION HOLES (FROM 0.016" TO 0.0035" DIAMETER);4) MODIFIED TIP ELECTRODE MATERIAL (FROM 90% PLATINUM/10% IRIDIUM TO 80% PALLADIUM/20% PLATINUM); AND 5) UPDATE STOCKERT 70 RF GENERATOR SOFTWARE (VL.035 TO VL.037). THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAMES BI-DIRECTIONAL CARTO XP THERMOCOOL SF NAY CATHETER, BI-DIRECTIONAL CARTO 3 THERMOCOOL SF NAY CATHETER, AND BIDIRECTIONAL THERMOCOOL SF CATHETER AND IS INDICATED FOR: THE BIOSENSE WEBSTER THERMOCOOL SF NAV DIAGNOSTIC/ ABLATION DEFLECTABLE TIP CATHETER AND RELATED ACCESSORY DEVICES ARE INDICATED FOR CATHETER BASED CARDIAC ELECTROPHYSIOLOGICAL MAPPING (STIMULATING AND RECORDING) AND, WHEN USED WITH A COMPATIBLE RF GENERATOR, FOR THE TREATMENT OF 1) TYPE I ATRIAL FLUTTER IN PATIENTS AGE 18 OR OLDER; AND 2) DRUG REFRACTORY RECURRENT SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION, WHEN USED WITH COMPATIBLE THREE-DIMENSIONAL ELECTROANATOMIC MAPPING SYSTEMS. THE THERMOCOOL SF NAV DIAGNOSTIC/ ABLATION DEFLECTABLE TIP CATHETER PROVIDES LOCATION INFORMATION WHEN USED WITH COMPATIBLE CARTO EP NAVIGATION SYSTEMS.THE BIOSENSE WEBSTER THERMOCOOL SF DIAGNOSTIC/ABLATION DEFLECTABLE TIP CATHETER AND RELATED ACCESSORIES ARE INDICATED FOR USE IN CATHETER-BASED CARDIAC ELECTROPHYSIOLOGICAL MAPPING (STIMULATING AND RECORDING) AND, WHEN USED WITH A COMPATIBLE RF GENERATOR, FOR THE TREATMENT OF TYPE I ATRIAL FLUTTER IN PATIENTS AGE 18 OR OLDER.

Source documents

Other decisions for Biosense Webster, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.